ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Autologous Fresh Whole Blood and Coagulation Following Cardiopulmonary Bypass in Infants

This study has been completed.

Sponsored by: National Center for Research Resources (NCRR)
Information provided by: National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier: NCT00006186
  Purpose

Dilution of blood caused by cardiopulmonary bypass (the heart-lung machine) during open heart surgery is associated with decreased concentrations in the blood of coagulation factors. This can be extreme in infants because of their small blood volumes and can lead to impairment of the normal blood clotting mechanism and excessive bleeding after the operation. Transfusion of fresh whole blood has been shown to be an effective treatment because fresh blood is rich in coagulation factors. However, it is difficult to obtain truly fresh blood from a blood bank. We hypothesized that fresh blood drawn from the patient and given back after cardiopulmonary bypass would improve the clotting mechanism. In our study, the infants in the treatment group have some of their own fresh blood removed after they are anesthetized for the operation and before they are placed on cardiopulmonary bypass. This blood is then given back to them after completion of cardiopulmonary bypass. Infants in the control group will not have their own blood removed but will undergo cardiopulmonary bypass. We will compare the two groups by drawing blood samples that measure coagulation tests.


Condition Intervention
Congenital Heart Defects
Procedure: Autologous fresh whole blood

MedlinePlus related topics:   Congenital Heart Defects   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind, Parallel Assignment
  Eligibility
Ages Eligible for Study:   1 Month and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Undergoing non-complex open heart surgery
  • Diagnosis of congenital heart disease
  • No previous open heart surgery
  • Weight 15 kg or less
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00006186

Locations
United States, Colorado
Children's Hospital    
      Denver, Colorado, United States, 80218

Sponsors and Collaborators
  More Information


Study ID Numbers:   NCRR-M01RR00069-0621, M01RR00069
First Received:   August 25, 2000
Last Updated:   June 23, 2005
ClinicalTrials.gov Identifier:   NCT00006186
Health Authority:   United States: Federal Government

Keywords provided by National Center for Research Resources (NCRR):
dilutional coagulopathy  

Study placed in the following topic categories:
Heart Diseases
Cardiovascular Abnormalities
Blood Coagulation Disorders
Congenital Abnormalities
Hemostatic Disorders
Heart Defects, Congenital

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on October 03, 2008




Links to all studies - primarily for crawlers